ARTICLE
23 April 2024

Holland & Knight Health Dose: April 16, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: House Health Hearings
  • House E&C Committee Gears Up for Telehealth Waiver Authority Expirations
  • Senate Finance Committee Holds Hearing: Bolstering Chronic Care Through Medicare Physician Payment
  • FDA Commissioner Floats New FDA Pathway for Hemp-Derived CBD
  • Update on Bipartisan Privacy Rights Discussion Draft Legislation
  • Sen. Sanders Releases Long COVID Moonshot Draft Proposal

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More